Pharming Group reports financial results for full year 2022
Pharming Group N.V. presents its preliminary (unaudited) financial report for the full year ended December 31, 2022. Download the press release below.
"It was a year in which we prioritized our efforts in rare diseases and affirmed our commitment to our purpose of serving the unserved rare disease patient."- Sijmen de Vries | Chief Executive Officer